ARCHIVES

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

This article is from The Cancer Letter archive.

Vol. 15 No. 10 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer

February 26, 2010

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009

Two Breast Cancer Screening Methods Found Equivalent

August 29, 2008

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

Von Eschenbach Takes NCI’s Helm As Bush Proposes Budget Increase.

February 8, 2002